Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.59 |
| ▸ | CNR1 | P21554 | 3/20 | 0.55 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.52 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.52 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | HLCS | P50747 | 2/20 | 0.43 |
| ▸ | FABP3 | P05413 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165784 | 0.94 | CNR2 (0.66) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL10140249 | 0.94 | CNR2 (0.66) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL12989865 | 0.92 | CNR2 (0.68) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL29688513 | 0.88 | CNR2 (0.78) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL28660549 | 0.88 | CNR2 (0.59) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL12582940 | 0.87 | CNR2 (0.66) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL15746589 | 0.86 | CNR1 (0.64) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL29758823 | 0.85 | CNR2 (0.64) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL29910364 | 0.84 | CNR2 (0.73) | CNR2CNR1F2PRSS1PRSS2 | |
| SCHEMBL29700479 | 0.84 | CNR2 (0.67) | CNR2CNR1F2PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034372-B2 | Lipid construct for delivery of insulin to a mammal | SDG, INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-20150031608-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | SDG, INC. | 2015-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031608-A1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | INSR, IAPP, GPR119 | CNR2 1119/4885CNR1 719/4885F2 2597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.